The Effect of Short-Chain Fatty Acids on Growth of Cryptosporidium parvum In Vitro

Aidan P Keelaghan1,2, Raheela Charania1,2, Jan R Mead1,2

  • 1Department of Pediatrics, Emory University and Children's Healthcare Organization of Atlanta, Atlanta, GA 30322, USA.

Microorganisms
|September 23, 2022
PubMed

Insights

Short-chain fatty acids (SCFAs) like acetate, propionate, and butyrate inhibit Cryptosporidium parvum growth in host cells. Butyrate also reduces sporozoite infectivity, potentially managing infections.

Area of Science:

  • Parasitology
  • Cell Biology
  • Microbiology

Background:

  • Cryptosporidial infection severity correlates with reduced short-chain fatty acid (SCFA) levels.
  • SCFAs play a role in host-pathogen interactions and gut health.

Purpose of the Study:

  • To investigate the direct impact of SCFAs on Cryptosporidium parvum growth in human intestinal cells.
  • To explore the potential of SCFAs as a therapeutic strategy against cryptosporidiosis.

Main Methods:

  • Human ileocecal adenocarcinoma (HTC-8) cells were infected with C. parvum oocysts.
  • Cells were incubated with various SCFAs (acetate, butyrate, propionate, valproate) and parasite numbers quantified.
  • Mechanisms of inhibition, including apoptosis and cytokine induction, were examined.

Main Results:

  • Acetate, butyrate, propionate, and valproate significantly inhibited C. parvum growth (EC50: 4–10 mM).
  • Combined SCFAs showed enhanced efficacy; butyrate also inhibited sporozoite infectivity.
  • Butyrate treatment increased apoptosis and inflammatory cytokines in infected cells.

Conclusions:

  • Acetate, propionate, and butyrate exhibit direct inhibitory effects on C. parvum within host cells.
  • Butyrate possesses dual activity, inhibiting both intracellular parasites and extracellular sporozoites.
  • SCFAs may serve as a supportive measure to control C. parvum infection levels.

Related Concept Videos